Repligen (RGEN) Tops Q2 EPS by 5c, misses on revenue, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $177.39 -0.49%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.53, $0.05 better than the analyst estimate of $0.48. Revenue for the quarter came in at $159.2 million versus the consensus estimate of $165.93 million.
GUIDANCE:
Repligen sees FY2023 revenue of $635-665 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- CS Disco, Inc (LAW) Misses Q3 EPS by 6c; offers guidance
- Avnet (AVT) Tops Q1 EPS by 97c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
